Glycaemic Response to a Liquid Meal Tolerance Test

The purpose of this study is to assess whether added food ingredient(s) affect glycaemic responses to a liquid meal tolerance test (LMTT).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glycaemic Index Glycaemic Response

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Reading Scientific Services Limited (RSSL)

Reading, Berkshire, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female (not less than 40% Male)
Aged 18 - 55 years
Non Smokers
Have a body mass index between 18.5 to 29.99 kg/m2
Healthy, non-diabetic, no gastric bypass surgery
Not allergic to dairy, or soy
Have a fasting plasma glucose (finger-stick) <100 mg/dl (<5.5 mmol/L)
Willing and able to provide written informed consent

Treatment and study plan

Control drink

Other

Experimental Drink

Other

Primary outcomes

Glycaemic response (incremental area under the curve) of experimental test food using capillary blood

Time frame: 120 minutes

Sponsors and collaborators

Lead sponsor

Mondelēz International, Inc.

Industry

Collaborators

Reading Scientific Services Ltd.

Registry information

Official study title

Effects of Dehydrated Vegetable Powder on Glycaemic Responses to a Liquid Meal Tolerance Test (LMTT)

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2012
First posted: Sep 10, 2012
Registry last updated: May 9, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed